Lucas Ferrari De Andrade, PhD

Research Project:
Promoting Natural Killer Cell-driven Immunity Against Lung Cancer

Grant Awarded:

Lung Cancer Discovery Award

Research Topics:

combination therapies experimental therapeutics
immunology immunotherapy

Research Disease:

lung cancer

The immune system plays a pivotal role in the elimination of tumor cells and it can be harnessed for the development of immunotherapies. However, many patients with lung cancer are either resistant or develop acquired resistance to the current immunotherapies available. We are developing an alternative approach that has unique mechanism of action: it retains a key receptor on the surface of white blood cells for subsequent recognition and destruction of tumor cells. Our molecule is an antibody that works in conjunction with a standard antibody that is used for marking malignant cells. We propose to test these antibodies in combination in lung cancer models. In the short term, our studies will generate new information about how they harness the immune system to inhibit lung cancer. In the long term, our studies will help provide a new treatment for patients and could prolong their lives or even cure this disease.

Page last updated: October 3, 2023

Join the Patient & Caregiver Network

End Youth Vaping

10 Tips to Protect Yourself from Unhealthy Air

State of the Air Key Findings

Become an Advocate

Events Near You

Lucas Ferrari De Andrade, PhD

A Breath of Fresh Air in Your Inbox

Thank You!

Make a Donation

Become a Lung Health Insider

Select Your Location

Change Language

Lung HelpLine

1-800-LUNG-USA